Connect your AI

Veracyte VCYT Lease Liability Payments - 2020 (Remaining Three Months)

Lease Liability Payments - 2020 (Remaining Three Months) at other companies

Guardant HealthGH

——

Natera, Inc.NTRA

——

Bio-Rad LaboratoriesBIO

——

Idexx LaboratoriesIDXX

——

Other financials

Income statement

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

Market cap$4.29B+10.7%

Profitability

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's lease liability payments - 2020 (remaining three months).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Veracyte's lease liability payments - 2020 (remaining three months)?: Veracyte (VCYT) reported lease liability payments - 2020 (remaining three months) of $2.95M in Q1 2026.
How has Veracyte's lease liability payments - 2020 (remaining three months) changed year-over-year?: Veracyte's lease liability payments - 2020 (remaining three months) decreased by 52.0% year-over-year, from $6.15M to $2.95M.